MOCLOBEMIDE TWICE-DAILY IN THE TREATMENT OF MAJOR DEPRESSIVE EPISODE - A DOUBLE-BLIND, MULTICENTER COMPARISON WITH DIFFERENT 3 TIMES DAILY DOSAGE SCHEDULES
Version 2 2024-05-30, 08:53Version 2 2024-05-30, 08:53
Version 1 2015-03-18, 12:10Version 1 2015-03-18, 12:10
conference contribution
posted on 2024-05-30, 08:53authored byCA GAGIANO, FGM MULLER, Michael BerkMichael Berk, PM JOUBERT, RGCW BROWN, R SCHALL
MOCLOBEMIDE TWICE-DAILY IN THE TREATMENT OF MAJOR DEPRESSIVE EPISODE - A DOUBLE-BLIND, MULTICENTER COMPARISON WITH DIFFERENT 3 TIMES DAILY DOSAGE SCHEDULES
Symposium on Recent Clinical Developments with Reversible and Selective Amine Oxidase Inhibitors, at the 19th Congress of the Collegium-Internationale-Neuro-Psychopharmacologicum